Illumina forecasts 2026 EPS of $5.40-$5.45 while raising revenue outlook to $4.64B-$4.66B (NASDAQ:ILMN)
· seekingalpha.com
Illumina Q3 2026 earnings: raised guidance, strong NovaSeq X demand, and clinical sequencing growth.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...